期刊
CANCER LETTERS
卷 414, 期 -, 页码 16-25出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2017.10.031
关键词
tRNA-derived fragments; Cancer progression; Gene regulation; Biomarker
类别
资金
- National Natural Science Foundation of China [81172503, 81572603, 81302304, 81402139, 81570804]
- Project of Invigorating Health Care through Science, Technology and Education (Jiangsu Provincial Medical Talent) [ZDRCA2016023]
- Project of Invigorating Health Care through Science, Technology and Education (Jiangsu Provincial Medical Youth Talent) [QNRC2016095]
Transfer RNAs (tRNAs) were traditionally considered to participate in protein translation. Recent studies have identified a novel class of small non-coding RNAs (sncRNAs), produced by the specific cleavage of pre- and mature tRNAs, which have been named tRNA-derived fragments. tRNA-derived fragments are classified into diverse subtypes based on the different cleavage positions of the pre- and mature tRNAs. Recently, accumulated evidence has shown that these tRNA-derived fragments are frequently dysregulated in several cancers. Several tRNA-derived fragments were found to participate in cell proliferation, apoptosis, and invasive metastasis in several malignant human tumors. These dysregulated fragments are able to bind both Argonaute proteins and Piwi proteins to regulate gene expression. Some of the newly identified tRNA-derived fragments have been considered as the new biomarkers and therapeutic targets for the treatment of cancer. This review summarizes the biogenesis and biological functions of different subtypes of tRNA-derived fragments and discusses their molecular mechanisms in cancer progression. (c) 2017 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据